about
Nitric oxide and peroxynitrite in health and diseaseImmunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness.Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.Drug treatment of multiple sclerosis. Clinical review was unsystematic.Disease modifying agents for multiple sclerosis.Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value.Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute AttacksBlocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation.Pathophysiology of multiple sclerosis and the place of teriflunomide.Effects of adjunct glucosamine sulfate on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized, placebo-controlled trial.Seizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta-1a and clomipramine.Caregivers of people with multiple sclerosis: experiences of support.
P2860
Q24645400-905320B2-2B9B-44A2-9B11-18BA9337368BQ30666435-F1C9D01A-6ADB-4280-A87E-00064674EBCFQ31017620-638AD30D-B4FA-48D5-BD82-CF8BDADA0F95Q33803981-078A4103-9A5A-4D99-A5B1-49CD9F3E0E9EQ34508451-BCDB1052-DA36-471F-AD13-8418D46DFB72Q34515581-C650371B-4735-4B70-99D1-24A6EC304375Q35876398-D6948C50-C791-4921-A492-4CCE3CDCE91BQ35915016-6ACD66E7-F6C5-48ED-860A-60B0A4AFA41AQ36395232-C67A2736-F6B7-4AD8-BFA4-10B25109317FQ36516815-6B82DCD9-C521-438C-BC86-5B5055AA4D77Q37794267-93574C52-5163-4246-B5EE-3B6EE32B1AC3Q43133299-DD7475EA-C381-46B9-A3E8-AAA823FE4844Q44217127-26662DB7-EFD5-487C-B850-B6EA666E3C8BQ53896428-CA5B29BA-E780-4C65-8953-6C5ACCF4AABD
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drug treatment of multiple sclerosis
@ast
Drug treatment of multiple sclerosis
@en
Drug treatment of multiple sclerosis
@nl
type
label
Drug treatment of multiple sclerosis
@ast
Drug treatment of multiple sclerosis
@en
Drug treatment of multiple sclerosis
@nl
prefLabel
Drug treatment of multiple sclerosis
@ast
Drug treatment of multiple sclerosis
@en
Drug treatment of multiple sclerosis
@nl
P2860
P356
P1433
P1476
Drug treatment of multiple sclerosis
@en
P2093
B M Uitdehaag
C H Polman
P2860
P304
P356
10.1136/BMJ.321.7259.490
P407
P577
2000-08-01T00:00:00Z